S. Tsimikas
Surgery · 2005–2020
A researcher in the Science corpus: 5 papers; trusts 3 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Surgery — 27 citations into it; #938 of 1,106 by trust here, #592 by citations
- Cancer Research — 9 citations into it
- Endocrinology, Diabetes and Metabolism — 5 citations into it
Whom S. Tsimikas trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts S. Tsimikas overall
Papers from S. Tsimikas's perspective
Ordered by how strongly the researchers S. Tsimikas trusts endorse each paper. Same corpus, a different order for every researcher.
- Lipoprotein(a) as a cardiovascular risk factor: current status (European Heart Journal)
- Genetic variants associated with Lp(a) lipoprotein level and coronary disease. (New England Journal of Medicine)
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. (New England Journal of Medicine)
- Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population
- 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. (Canadian Journal of Cardiology)
- Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial (Circulation)
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials. (The Lancet)
- Decoding the Patterns of Self and Nonself by the Innate Immune System (Science)
- Large-scale association analysis identifies new risk loci for coronary artery disease
- ESC/EAS Guidelines for the Management of Dyslipidaemias
Their papers
- Oxidation-Specific Epitopes are Danger Associated Molecular Patterns Recognized by Pattern Recognition Receptors of Innate Immunity (2011) — 641 citations
- Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. (2020) — 825 citations
- A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies. (2017) — 991 citations
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials. (2016) — 686 citations
- Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. (2005) — 766 citations